Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Report: Mnuchin Proposes FDA Branch in Israel, Meets With Health Officials
Error: Contact form not found.
by JNS.org
US Secretary of the Treasury Steven Mnuchin. Photo: Ricky Harris / The White House.
JNS.org – US Treasury Secretary Steven Mnuchin met on Tuesday with Israeli health officials to discuss opening an Israeli branch of the US Food and Drug Administration (FDA), a Treasury spokesperson told JNS.
Calcalist first reported the meeting.
The meeting, which included Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, as well as senior executives from Israeli health-maintenance organization Clalit and Sheba Medical Center, was held at the home of US Ambassador to Israel David Friedman in Herzliya.
The FDA has few branches outside the United States, including those in China, and several European and Latin American nations.
“At first glance, Israel is too small to meet the FDA criteria for a local branch, but the matter is being considered due to the country’s unusually large concentration of biotech and medtech companies,” reported Calcalist, citing a source familiar with the matter. “While it will not replace the need to apply for FDA clearance in the US, it could shorten the application process for Israeli companies.”
Estimates are that such a branch could be established in Israel in the near future, the person said.
